Archives

While the anecdotal accounts are compelling, significant questions remain around how microdosing works, and how much of the reported benefits are due to pharmacological effects, rather than [...]

People who use drugs understand drugs and drug use in ways that are often different to the way knowledge of drug use is constructed within the dominant medico-legal discourse. Their experiences [...]

Dr Bright said Australia had the opportunity to “scale up”, with bigger trials ensuring more therapists were trained so when MDMA was given the green light in the US, the safety data [...]

There is increasing evidence that psychedelic-assisted psychotherapy is effective for a range of psychological conditions. There are likely numerous mechanisms of action that contribute to these [...]

Prestigious international institutions have initiated robust psychedelic research programs. Does Australia risk being left behind if it doesn’t do the same?

New research published in the Australian Psychologist Journal claims Australia is missing out on the benefits of using psychedelic drugs to treat a range of mental health illnesses.

Australia is missing out on a global “renaissance” of research into use of psychedelic drugs to treat mental health problems, two psychologists say.

Scientists believe the illegal drug MDMA, also known as ecstasy, has an untapped potential to treat post-traumatic stress disorder (PTSD). But they say plans to test the drug on war veterans in [...]

PRISM Vice President Dr Stephen Bright reflects on his attendance as a guest speaker at Beyond Psychedelics 2016 in Prague.

Dr Stephen Bright talks to The Psychedelia Podcast about the problems facing the psychedelic movement in Australia

Dr Stephen Bright, a Psychologist working at Curtin University discusses psychedelic therapy.

Paul Gregoire from Sydney Criminal Lawyers spoke with PRISM’s Dr Stephen Bright about treating PTSD with MDMA-assisted therapy.

In September 2016 PRISM’s Vice President Dr Stephen Bright spoke at Beyond Psychedelics, a global multidisciplinary psychedelic forum held in Prague, Czech Republic.

Could returned servicemen with war-ravaged hearts and minds soon be given MDMA to smooth their way back into society?

A recent review in Pharmacological Reviews highlights that over the last decade, a renaissance has occurred in psychedelic drug research

Click here to listen: https://soundcloud.com/enpsychedelia/the-psychedelic-inquirer-prism-interview

Some drugs that have therapeutic benefits are banned because of emerging patterns of use that do not conform to dominant paradigms. Such policies are often driven by morality rather than evidence.

In April 2014 PRISM’s President Martin Williams and Vice President Stephen Bright were invited to join a panel discussion at the Melbourne screening of Neurons to Nirvana,

Illegal recreational drugs including LSD, ecstasy and cannabis should be considered as alternative treatments for conditions such as post-traumatic stress disorder and anxiety,

4BC Health and Wellbeing: MDMA has been proven to help treat Post Traumatic Stress Disorder Research suggests that Psychoactive drugs like MDMA and LSD have other therapeutic benefits.

PRISM will be presenting a panel discussion at the 2013 Australian Professional Society on Alcohol and other Drugs Scientific Conference 24-27 November in Brisbane.

Story by Jill Stark, published in The Sunday Age (Melbourne) ECSTASY pills would be given to Australian bushfire victims, flood survivors and soldiers suffering post-traumatic stress disorder,